As the authors point out, long-term proton pump inhibitor use is connected to serious side effects and increases the risk of some other potentially serious conditions such as Clostridium difficile associated diarrhea, osteoporosis, and vitamin or electrolyte malabsorption
Consumed less, yet still desired The study found that current and previous users of GLP-1s reported reduced consumption of most foods and beverages
Both drugs are administered once a week with a sub-Q injection
We Dont Recommend Gentle Patches Gentle Patches are not real GLP-1 medications
Key Figures at a Glance Eli Lilly Q1 2026: total revenue $19.8B (+56% YoY), adjusted EPS $8.55 (+156%), full-year guidance raised to $82-85B Mounjaro + Zepbound combined Q1 revenue: $12.8B, with Mounjaro at $8.66B and Zepbound at $4.16B Foundayo (orforglipron): FDA approved April 1, 2026
The subscription bundles medication, provider consultation, and shipping